ML19010A096: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| Line 19: | Line 19: | ||
=Text= | =Text= | ||
{{#Wiki_filter: | {{#Wiki_filter:February 13, 2019 Gregory Piefer, Ph.D. | ||
Chief Executive Officer SHINE Medical Technologies, Inc. | |||
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 | |||
/RA/}} | ==SUBJECT:== | ||
SHINE MEDICAL TECHNOLOGIES, INC. - NOTICE OF CONSIDERATION OF APPROVAL OF INDIRECT LICENSE TRANSFER AND CONFORMING AMENDMENT AND OPPORTUNITY FOR A HEARING AND PETITION FOR LEAVE TO INTERVENE (EPID NO. L-2018-LLM-0154) | |||
==Dear Dr. Piefer:== | |||
Enclosed is a copy of a Notice of Consideration of Approval of the Indirect License Transfer and Conforming Amendment and Opportunity for a Hearing and Petition for Leave to Intervene related to the application dated December 11, 2018 (Agencywide Documents Access and Management System Accession No. ML18347A215), filed by SHINE Medical Technologies, Inc. | |||
(SHINE). Pursuant to Title 10 of the Code of Federal Regulations Section 50.80, Transfer of licenses, the application seeks U.S. Nuclear Regulatory Commission approval of the proposed indirect transfer of Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility, currently held by SHINE. The indirect transfer will result from the establishment of a holding company, Illuminated Holdings, Inc. (Illuminated). | |||
The application also seeks, pursuant to 10 CFR 50.90, Application for amendment of license, construction permit, or early site permit, the issuance of a conforming amendment to the license to reflect the indirect transfer. The conforming administrative amendment would revise SHINEs construction permit to reflect SHINEs new name, SHINE Medical Technologies, LLC, resulting from its conversion from a corporation into a single-member limited liability company, owned and controlled by Illuminated. | |||
The notice of consideration of the approval of SHINEs application for indirect license transfer of Construction Permit No. CPMIF-001 and for the issuance of a conforming amendment provides a 20-day opportunity to request a hearing and petition for leave to intervene. | |||
G. Piefer This notice is being forwarded to the Office of the Federal Register for publication. If you have any questions, please contact me at (301) 415-1524 or by electronic mail at Steven.Lynch@nrc.gov. | |||
Sincerely, | |||
/RA/ | |||
Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-608 | |||
==Enclosure:== | |||
As stated cc: See next page | |||
SHINE Medical Technologies, Inc. Docket No. 50-608 cc: | |||
Jeff Bartelme Licensing Manager SHINE Medical Technologies, Inc. | |||
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 Jeff Chamberlin National Nuclear Security Administration, NA-231 U.S. Department of Energy 1000 Independence Ave SW Washington, DC 20585 Mark Paulson Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 Test, Research and Training Reactor Newsletter Attention: Amber Johnson Dept of Materials Science and Engineering University of Maryland 4418 Stadium Dr. | |||
College Park, MD 20742-2115 Mark Freitag City Manager P.O. Box 5005 Janesville, WI 53547-5005 Bill McCoy 1326 Putnam Avenue Janesville, WI 53546 Alfred Lembrich 541 Miller Avenue Janesville, WI 53548 Gerald and Muriel Bumgarner 1735 S Osborne Ave Janesville, WI 53546 | |||
PKG ML19010A095; LTR (NRR-106) ML19010A096; FRN (ADM-012) | |||
ML19010A097; Withholding LTR: ML19010A172 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/LA OGC NAME SLynch NParker MYoung DATE 1/17/2019 1/17/2019 1/29/2019 OFFICE NRR/DLP/PFPB/BC NRR/DLP/PRLB/ABC NRR/DLP/PRLB/PM NAME ABowers WKennedy SLynch DATE 2/12/2019 2/13/2019 2/13/2019}} | |||
Revision as of 07:05, 20 October 2019
| ML19010A096 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 02/13/2019 |
| From: | Steven Lynch Research and Test Reactors Licensing Projects Branch |
| To: | Piefer G SHINE Medical Technologies |
| Lynch S, NRR/DLP, 415-1524 | |
| Shared Package | |
| ML19010A095 | List: |
| References | |
| EPID L-2018-LLM-0154 | |
| Download: ML19010A096 (5) | |
Text
February 13, 2019 Gregory Piefer, Ph.D.
Chief Executive Officer SHINE Medical Technologies, Inc.
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, INC. - NOTICE OF CONSIDERATION OF APPROVAL OF INDIRECT LICENSE TRANSFER AND CONFORMING AMENDMENT AND OPPORTUNITY FOR A HEARING AND PETITION FOR LEAVE TO INTERVENE (EPID NO. L-2018-LLM-0154)
Dear Dr. Piefer:
Enclosed is a copy of a Notice of Consideration of Approval of the Indirect License Transfer and Conforming Amendment and Opportunity for a Hearing and Petition for Leave to Intervene related to the application dated December 11, 2018 (Agencywide Documents Access and Management System Accession No. ML18347A215), filed by SHINE Medical Technologies, Inc.
(SHINE). Pursuant to Title 10 of the Code of Federal Regulations Section 50.80, Transfer of licenses, the application seeks U.S. Nuclear Regulatory Commission approval of the proposed indirect transfer of Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility, currently held by SHINE. The indirect transfer will result from the establishment of a holding company, Illuminated Holdings, Inc. (Illuminated).
The application also seeks, pursuant to 10 CFR 50.90, Application for amendment of license, construction permit, or early site permit, the issuance of a conforming amendment to the license to reflect the indirect transfer. The conforming administrative amendment would revise SHINEs construction permit to reflect SHINEs new name, SHINE Medical Technologies, LLC, resulting from its conversion from a corporation into a single-member limited liability company, owned and controlled by Illuminated.
The notice of consideration of the approval of SHINEs application for indirect license transfer of Construction Permit No. CPMIF-001 and for the issuance of a conforming amendment provides a 20-day opportunity to request a hearing and petition for leave to intervene.
G. Piefer This notice is being forwarded to the Office of the Federal Register for publication. If you have any questions, please contact me at (301) 415-1524 or by electronic mail at Steven.Lynch@nrc.gov.
Sincerely,
/RA/
Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-608
Enclosure:
As stated cc: See next page
SHINE Medical Technologies, Inc. Docket No. 50-608 cc:
Jeff Bartelme Licensing Manager SHINE Medical Technologies, Inc.
101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 Jeff Chamberlin National Nuclear Security Administration, NA-231 U.S. Department of Energy 1000 Independence Ave SW Washington, DC 20585 Mark Paulson Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 Test, Research and Training Reactor Newsletter Attention: Amber Johnson Dept of Materials Science and Engineering University of Maryland 4418 Stadium Dr.
College Park, MD 20742-2115 Mark Freitag City Manager P.O. Box 5005 Janesville, WI 53547-5005 Bill McCoy 1326 Putnam Avenue Janesville, WI 53546 Alfred Lembrich 541 Miller Avenue Janesville, WI 53548 Gerald and Muriel Bumgarner 1735 S Osborne Ave Janesville, WI 53546
PKG ML19010A095; LTR (NRR-106) ML19010A096; FRN (ADM-012)
ML19010A097; Withholding LTR: ML19010A172 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/LA OGC NAME SLynch NParker MYoung DATE 1/17/2019 1/17/2019 1/29/2019 OFFICE NRR/DLP/PFPB/BC NRR/DLP/PRLB/ABC NRR/DLP/PRLB/PM NAME ABowers WKennedy SLynch DATE 2/12/2019 2/13/2019 2/13/2019